| This article has been cited by |
| 1 | Pharmacovigilance: A Worldwide Master Key for Drug Safety Monitoring: Some Additional | |
| C. Patel |
| Journal of Young Pharmacists.2011;3(2)168 |
| [DOI] |
|
| 2 | Assessment of attitudes towards adverse events following immunization with oral poliovirus vaccine: a pilot study among high school students of Kinshasa, the Democratic Republic of Congo | |
| Léon Kinuani,Didier Bomene Nzolo,Michel Ntetani Aloni,Pavel Makolo,Nsengi Ntamabyaliro,Yves Lula Ntamba,Crispin Kazadi,Michel Nyembwe,Mathilde Bothale Ekila,Gauthier Kahunu Mesia |
| Pathogens and Global Health.2014;108(6)292 |
| [DOI] |
|
| 3 | Vaccine Adverse Event Mining of Twitter Conversations: 2-Phase Classification Study | |
| Sedigheh Khademi Habibabadi,Pari Delir Haghighi,Frada Burstein,Jim Buttery |
| JMIR Medical Informatics.2022;10(6)e34305 |
| [DOI] |
|
| 4 | Active surveillance of adverse events following immunization (AEFI): a prospective 3-year vaccine safety study | |
| Juny Sebastian,Parthasarathi Gurumurthy,Mandyam Dhati Ravi,Madhan Ramesh |
| Therapeutic Advances in Vaccines and Immunotherapy.2019;7(6)251513551988900 |
| [DOI] |
|
